Singular Genomics Systems, Inc. (OMIC) Stock Overview
Explore Singular Genomics Systems, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Singular Genomics Systems, Inc. (OMIC)
Key Financials
Key Financials
Market Cap
50.8M
P/E Ratio
-0.51
EPS (TTM)
$-34.68
ROE
-0.43%
OMIC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Singular Genomics Systems, Inc. (NASDAQ: OMIC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Singular Genomics Systems, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of OMIC on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $13.23 for the NASDAQ listing.
Key metrics behind Singular Genomics Systems, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.51 and a market capitalization of 50.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OMIC on the NASDAQ.